Overview

Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effectiveness of escitalopram to prevent depression in head and neck cancer patients receiving treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of Nebraska
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Citalopram
Dexetimide